Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Exchange: New York
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Generic Drugs

Teva Pharmaceutical Industries Ltd

+ Add to Watchlist

TEVA:US

39.3400 USD 0.1500 0.38%

As of 20:04:02 ET on 05/24/2013.

Company Profile for Teva Pharmaceutical Industries Ltd (TEVA)

Teva Pharmaceutical Industries Ltd., is a global pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients.

Contact Information

Teva Pharmaceutical Industries Ltd

5 Basel Street
PO Box 3190
Petach Tikva
Israel
Phone: 972-3-914-8171
Fax: 972-3-914-8678

Key Executives for Teva Pharmaceutical Industries Ltd (TEVA)

Phillip FrostChairmanJeremy M LevinPresident/CEO
Allan ObermanPresident & CEO:AmericasRobert Koremans "Rob"President & CEO:Europe
Carlo De NotaristefaniPresident & CEO:Global OpsJudith VardiPresident & CEO:Emia & Asia Pacific
Michael R HaydenPres:Global R&D/Chief Scientific OfcrEyal DeshehGroup Exec VP/CFO
Richard S EgosiGroup Exec VP/Chief Legal Ofcr/SecyPaul J SekhriGroup Exec VP:Global/Chief Strategy Ofcr
Aharon Yaari "Arik"Group Exec VP:InstitutionalIsaac Abravanel "Ica"Group Exec VP:Human Resources
Kevin C MannixVP/Head:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil